mRNA |
WP1130 |
CTRPv2 |
pan-cancer |
AAC |
0.022 |
0.5 |
mRNA |
tandutinib |
CTRPv2 |
pan-cancer |
AAC |
-0.023 |
0.5 |
mRNA |
JQ-1:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.02 |
0.5 |
mRNA |
JQ-1:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.021 |
0.5 |
mRNA |
paclitaxel |
CTRPv2 |
pan-cancer |
AAC |
-0.02 |
0.5 |
mRNA |
CI-976 |
CTRPv2 |
pan-cancer |
AAC |
0.024 |
0.5 |
mRNA |
BRD-K41597374 |
CTRPv2 |
pan-cancer |
AAC |
-0.021 |
0.5 |
mRNA |
Carboplatin |
CTRPv2 |
pan-cancer |
AAC |
-0.022 |
0.5 |
mRNA |
canertinib |
CTRPv2 |
pan-cancer |
AAC |
-0.022 |
0.5 |
mRNA |
navitoclax:pluripotin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.022 |
0.5 |